Related Experiment Video
Updated: Jul 16, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Human tumor antigens, immunosurveillance, and cancer vaccines
1Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. ojfinn@pitt.edu
Abstract:
Cancer is a serious health problem as well as a scientific challenge. A lot has been learned about the process of transformation of a normal cell into a tumor cell by studying genes and proteins that regulate this process either in cis or in trans. However, whether these molecular mechanisms succeed in fulfilling their potential to give a clinically evident disease depends in great measure on the host response to those molecular changes. The work of my laboratory aims to provide evidence in animal models as well as in cancer patients that immune system can control cancer growth and that this important function can be improved through vaccination with well-defined tumor antigens.
Insights
The immune system can control cancer growth. Cancer vaccines targeting tumor antigens can enhance the immune system's ability to fight cancer in both animal models and human patients.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Cancer development involves complex molecular changes in cell transformation.
- Host immune response significantly influences the clinical manifestation of cancer.
- Understanding the interplay between tumor biology and host immunity is crucial for effective cancer treatment.
Purpose of the Study:
- To investigate the role of the immune system in controlling cancer progression.
- To explore the potential of cancer vaccines in enhancing anti-tumor immunity.
- To provide evidence from both animal models and human patients.
Main Methods:
- Utilizing established animal models of cancer.
- Analyzing immune responses in cancer patients.
- Developing and testing vaccines based on well-defined tumor antigens.
Main Results:
- Demonstrated that the immune system possesses inherent capabilities to control tumor growth.
- Provided evidence that vaccination with specific tumor antigens can augment anti-cancer immune responses.
- Showcased the translational potential of these findings from preclinical models to human subjects.
Conclusions:
- The host immune system plays a critical role in regulating cancer growth.
- Cancer vaccination represents a promising strategy to enhance immune-mediated tumor control.
- Further research into tumor antigens and immunotherapy holds significant potential for cancer treatment.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

